A new Helldivers 2 patch has been deployed, finally fixing the CE-27 Ground Breaker armor. Players were quick to notice, however, that the Ground Breaker wasn't working as intended, confusing ...

Yep, that new CE-27 Ground Breaker armor released as part of the latest Helldivers 2 Warbond really was meant to have a different passive installed, and the devs at Arrowhead are already working ...

TO address the region's affordable housing needs, Haus Talk Inc. (HTI) held groundbreaking rites for two new projects in Antipolo City, which offer a serene, accessible escape from the urban hustle.

Helldivers 2 players have served crushing blows to the ... but this MO is set up so that players are intentionally going to lose ground on one of the two fronts," community manager Spitz reveals ...

After climbing to this intraday high, GGPL shares went on to lock in a 5 percent upper circuit as well during ... issuance of 1:20 bonus shares and a 1:2 stock split. This was the second time ...

Three men and a minor girl were buried alive and two others were injured in Arjun Nagar after a wall of the Madanpuri cremation ground collapsed on Saturday evening. (Parveen Kumar/HT PHOTO ...

Another Helldivers 2 update has deployed in-game with this patch fixing a bug relating to one of the brand new armour sets Fixed multiple crashes that could occur in the loadout screen when other ...

Luis Kumar, an executive of the GMRSC, said, “We are excited to welcome Marics & Company Limited on board as the official partner of the Group 2 class for our 2024 Circuit Championship season.”.

Greg Gianforte, broke ground Thursday on the first phase of a long-awaited project bringing sidewalks to a stretch of busy U.S. 2. "Like I said: Out with the cowpaths, in with the sidewalks ...

The Dow Jones Industrial Average rose 0.8% and the Nasdaq composite gained 1.2%. Technology companies accounted for a big share of the rally. Chipmaking giant Nvidia rose 2.4% and Google’s ...

The cancer vaccine failed to trigger hoped-for changes in circulating tumor DNA (ctDNA), causing the phase 2 trial to miss its primary endpoint and leaving the biotech clinging to immature ...